{Reference Type}: Journal Article
{Title}: Interplay between caveolin-1 and mineralocorticoid receptor in cardiometabolic disease.
{Author}: Czarzasta K;Pojoga LH;
{Journal}: J Endocrinol
{Volume}: 262
{Issue}: 3
{Year}: 2024 Sep 1
{Factor}: 4.669
{DOI}: 10.1530/JOE-23-0341
{Abstract}: Over the past decades, research has clearly established the important role of the mineralocorticoid receptor (MR) in both renal and extra-renal tissues. Recently, caveolin-1 (Cav-1) has emerged as a mediator of MR signaling in several tissues, with implications on cardiovascular and metabolic dysfunction. The main structural component of caveolae (plasma membrane invaginations with diverse functions), Cav-1 is a modulator of cardiovascular function, cellular glucose, and lipid homeostasis, via its effects on signal transduction pathways that mediate inflammatory responses and oxidative stress. In this review, we present evidence indicating an overlap between the roles of the MR and Cav-1 in cardiometabolic disease and the relevant signaling pathways involved. Furthermore, we discuss the potential use of Cav-1 as a biomarker and/or target for MR-mediated dysfunction.